Publication
A brief overview of the oral delivery of insulin as an alternative to the parenteral delivery
dc.contributor.author | Macedo, Ana | |
dc.contributor.author | Filipe, Patricia | |
dc.contributor.author | Thome, Natalia G. | |
dc.contributor.author | Vieira, Joao | |
dc.contributor.author | Oliveira, Carolina | |
dc.contributor.author | Teodosio, Catarina | |
dc.contributor.author | Ferreira, Raquel | |
dc.contributor.author | Roque, Luis | |
dc.contributor.author | Fonte, Pedro | |
dc.date.accessioned | 2021-06-24T11:36:09Z | |
dc.date.available | 2021-06-24T11:36:09Z | |
dc.date.issued | 2020 | |
dc.description.abstract | Diabetes mellitus greatly affects the quality of life of patients and has a worldwide prevalence. Insulin is the most commonly used drug to treat diabetic patients and is usually administered through the subcutaneous route. However, this route of administration is ineffective due to the low concentration of insulin at the site of action. This route of administration causes discomfort to the patient and increases the risk of infection due to skin barrier disturbance caused by the needle. The oral administration of insulin has been proposed to surpass the disadvantages of subcutaneous administration. In this review, we give an overview of the strategies to deliver insulin by the oral route, from insulin conjugation to encapsulation into nanoparticles. These strategies are still under development to attain efficacy and effectiveness that are expected to be achieved in the near future. | |
dc.description.sponsorship | FEDER - Fundo Europeu de Desenvolvimento Regional funds through the COMPETE 2020 Operational Programme for Competitiveness and Internationalization (POCI) | |
dc.description.sponsorship | Portuguese funds through FCT - Fundacao para a Ciencia e a Tecnologia [POCI-01-0145-FEDER032610 -PTDC/MECDER/32610/2017] | |
dc.description.version | info:eu-repo/semantics/publishedVersion | |
dc.identifier.doi | 10.2174/1566524019666191010095522 | |
dc.identifier.issn | 1566-5240 | |
dc.identifier.uri | http://hdl.handle.net/10400.1/16646 | |
dc.language.iso | eng | |
dc.peerreviewed | yes | |
dc.publisher | Bentham Science Publishers | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0 | |
dc.subject | Diabetes mellitus | |
dc.subject | Insulin | |
dc.subject | Oral delivery | |
dc.subject | Nanoparticle | |
dc.subject | Absorption enhancer | |
dc.subject | Enzyme inhibitor | |
dc.subject | Intestinal patch | |
dc.title | A brief overview of the oral delivery of insulin as an alternative to the parenteral delivery | |
dc.type | journal article | |
dspace.entity.type | Publication | |
oaire.citation.endPage | 143 | |
oaire.citation.issue | 2 | |
oaire.citation.startPage | 134 | |
oaire.citation.title | Current Molecular Medicine | |
oaire.citation.volume | 20 | |
person.familyName | Fonte | |
person.givenName | Pedro | |
person.identifier.ciencia-id | 2410-123D-3385 | |
person.identifier.orcid | 0000-0002-1115-9282 | |
person.identifier.rid | K-3215-2013 | |
person.identifier.scopus-author-id | 55146900200 | |
rcaap.rights | restrictedAccess | |
rcaap.type | article | |
relation.isAuthorOfPublication | a5a5c2b2-9112-4bf4-8618-8c2051bbc116 | |
relation.isAuthorOfPublication.latestForDiscovery | a5a5c2b2-9112-4bf4-8618-8c2051bbc116 |
Files
Original bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- A Brief Overview of the Oral Delivery.pdf
- Size:
- 2.22 MB
- Format:
- Adobe Portable Document Format